Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Galenica and Memorial Sloan-Kettering initiate phase I trial of prostate cancer treatment

July 26, 2000

Pharmacyclics updates Xcytrin clinical trial progress

July 25, 2000

Photofrin distribution agreement established

July 25, 2000

Vion begins phase I trial of intravenous TAPET at Royal Marsden Hospital

July 25, 2000

Licensing opportunity from Immunex: interleukin-15 (IL-15)

July 24, 2000

Yeda presents new agents for PDT of tumors

July 24, 2000

Combination therapy with G-3139 and dacarbazine as new approach to malignant melanoma

July 24, 2000

Titan acquires novel agent for the treatment of cancer and viral disease

July 24, 2000

Valtaxin approved in Canada for CIS of the bladder

July 24, 2000

NeoPharm seeks clearance to begin clinical development of LE-AON

July 21, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...